{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:48:51Z","timestamp":1785577731194,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1038\/nrmicro930","type":"journal-article","created":{"date-parts":[[2004,6,15]],"date-time":"2004-06-15T19:30:21Z","timestamp":1087327821000},"page":"602-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Rapid response research to emerging infectious diseases: lessons from SARS"],"prefix":"10.1038","volume":"2","author":[{"given":"B. Brett","family":"Finlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrmicro930_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1005277213366","volume":"26","author":"GC Kombe","year":"2001","unstructured":"Kombe, G. C. & Darrow, D. M. Revisiting emerging infectious diseases: the unfinished agenda. J. Commun. Health 26, 113\u2013122 (2001).","journal-title":"J. Commun. Health"},{"key":"BFnrmicro930_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00430-002-0122-5","volume":"191","author":"H Feldmann","year":"2002","unstructured":"Feldmann, H. et al. Emerging and re-emerging infectious diseases. Med. Microbiol. Immunol. (Berl.) 191, 63\u201374 (2002).","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"BFnrmicro930_CR3","unstructured":"World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). [online], <http:\/\/www.who.int\/csr\/sars\/en\/WHOconsensus.pdf> (2003)."},{"key":"BFnrmicro930_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa030634","volume":"348","author":"SM Poutanen","year":"2003","unstructured":"Poutanen, S. M. et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995\u20132005 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro930_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.1085953","volume":"300","author":"MA Marra","year":"2003","unstructured":"Marra, M. A. et al. The genome sequence of the SARS-associated coronavirus. Science 300, 1399\u20131404 (2003).","journal-title":"Science"},{"key":"BFnrmicro930_CR6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1085952","volume":"300","author":"PA Rota","year":"2003","unstructured":"Rota, P. A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394\u20131399 (2003).","journal-title":"Science"},{"key":"BFnrmicro930_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(03)13414-9","volume":"361","author":"YJ Ruan","year":"2003","unstructured":"Ruan, Y. J. et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779\u20131785 (2003).","journal-title":"Lancet"},{"key":"BFnrmicro930_CR8","first-page":"362","volume":"11","author":"YJ Tan","year":"2004","unstructured":"Tan, Y. J. et al. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 11, 362\u2013371 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"BFnrmicro930_CR9","first-page":"227","volume":"11","author":"X Liu","year":"2004","unstructured":"Liu, X. et al. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin. Diagn. Lab. Immunol. 11, 227\u2013228 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"BFnrmicro930_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0140-6736(04)15729-2","volume":"363","author":"PC Woo","year":"2004","unstructured":"Woo, P. C. et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363, 841\u2013845 (2004).","journal-title":"Lancet"},{"key":"BFnrmicro930_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0166-0934(97)00170-5","volume":"70","author":"A Ndifuna","year":"1998","unstructured":"Ndifuna, A., Waters, A. K., Zhou, M. & Collisson, E. W. Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus. J. Virol. Methods 70, 37\u201344 (1998).","journal-title":"J. Virol. Methods"},{"key":"BFnrmicro930_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1086\/378587","volume":"37","author":"W Cui","year":"2003","unstructured":"Cui, W. et al. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 37, 857\u2013859 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro930_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2350-4-9","volume":"4","author":"M Lin","year":"2003","unstructured":"Lin, M. et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med. Genet. 4, 9 (2003).","journal-title":"BMC Med. Genet."},{"key":"BFnrmicro930_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-1135(93)90126-R","volume":"36","author":"CW Olsen","year":"1993","unstructured":"Olsen, C. W. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet. Microbiol. 36, 1\u201337 (1993).","journal-title":"Vet. Microbiol."},{"key":"BFnrmicro930_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/14760584.2.2.167","volume":"2","author":"RT Kenney","year":"2003","unstructured":"Kenney, R. T. & Edelman, R. Survey of human-use adjuvants. Expert Rev. Vaccines 2, 167\u2013188 (2003).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnrmicro930_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","volume":"18","author":"S Gurunathan","year":"2000","unstructured":"Gurunathan, S., Klinman, D. M. & Seder, R. A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18, 927\u2013974 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrmicro930_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/423240a","volume":"423","author":"RA Fouchier","year":"2003","unstructured":"Fouchier, R. A. et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).","journal-title":"Nature"},{"key":"BFnrmicro930_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","volume":"362","author":"T Kuiken","year":"2003","unstructured":"Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263\u2013270 (2003).","journal-title":"Lancet"},{"key":"BFnrmicro930_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.303.5660.944","volume":"303","author":"E Marshall","year":"2004","unstructured":"Marshall, E. & Enserink, M. Caution urged on SARS vaccines. Science 303, 944\u2013946 (2004).","journal-title":"Science"},{"key":"BFnrmicro930_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/425915a","volume":"425","author":"BE Martina","year":"2003","unstructured":"Martina, B. E. et al. SARS virus infection of cats and ferrets. Nature 425, 915 (2003).","journal-title":"Nature"},{"key":"BFnrmicro930_CR21","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","volume":"78","author":"K Subbarao","year":"2004","unstructured":"Subbarao, K. et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78, 3572\u20133577 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro930_CR22","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(03)14962-8","volume":"362","author":"W Gao","year":"2003","unstructured":"Gao, W. et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362, 1895\u20131896 (2003).","journal-title":"Lancet"},{"key":"BFnrmicro930_CR23","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.0401939101","volume":"101","author":"H Bisht","year":"2004","unstructured":"Bisht, H. et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl Acad. Sci. USA 101, 6641\u20136646 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro930_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature02463","volume":"428","author":"ZY Yang","year":"2004","unstructured":"Yang, Z. Y. et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428, 561\u2013564 (2004).","journal-title":"Nature"},{"key":"BFnrmicro930_CR25","first-page":"127","volume-title":"Vaccines, From Concept to Clinic","author":"JA Biddle","year":"1999","unstructured":"Biddle, J. A. in Vaccines, From Concept to Clinic (eds Paoletti, L. C. & McInnes, P. M.) 127\u2013174 (CRC Press, Boca Raton, 1999)."},{"key":"BFnrmicro930_CR26","first-page":"391","volume":"87","author":"N Allison","year":"2003","unstructured":"Allison, N. & Tranter, H. S. From vaccine research to manufacture: a guide for the researcher. Methods Mol. Med. 87, 391\u2013408 (2003).","journal-title":"Methods Mol. Med."},{"key":"BFnrmicro930_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1586\/14760584.2.4.465","volume":"2","author":"JF Viret","year":"2003","unstructured":"Viret, J. F., Gluck, R. & Moser, C. Development of a SARS vaccine: an industrial perspective on the global race against a global disease. Expert Rev. Vaccines 2, 465\u2013467 (2003).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnrmicro930_CR28","first-page":"345","volume-title":"The Vaccine Book","author":"N Baston","year":"2003","unstructured":"Baston, N., Glass, S. & Seiguer, E. in The Vaccine Book (eds Bloom, B. R. & Lambert, P. H.) 345\u2013370 (Academic Press, San Diego, 2003)."},{"key":"BFnrmicro930_CR29","unstructured":"Global Alliance for Vaccines and Immunization. How can public\u2013private partnerships accelerate the availability of vaccines for the developing world? [online], <http:\/\/www.gaviftf.org\/forum\/pdf_cd\/20CostRisk.pdf> (2001)."},{"key":"BFnrmicro930_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/382225","volume":"189","author":"JR La Montagne","year":"2004","unstructured":"La Montagne, J. R., Simonsen, L., Taylor, R. J. & Turnbull, J. Severe acute respiratory syndrome: developing a research response. J. Infect. Dis. 189, 634\u2013641 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro930_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrmicro775","volume":"1","author":"K Stadler","year":"2003","unstructured":"Stadler, K. et al. SARS \u2014 beginning to understand a new virus. Nature Review Microbiology. 1, 209\u2013218 (2003).","journal-title":"Nature Review Microbiology."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrmicro930.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro930","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrmicro930.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:28:19Z","timestamp":1744284499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["BFnrmicro930"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro930","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]},"assertion":[{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}